We found that heterozygous loss of BAP1—but rarely mutation—occurs in over a quarter of PDAs and 40% of acinar cell carcinomas (ACCs), a rare and distinct subtype of pancreatic cancer that infrequently harbors KRAS mutations. Here, KRAS is linked to pancreatic neoplasm.